{"analyses":[{"groupDescription":"Week 30","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.86","statisticalComment":"Significance level = 0.05","statisticalMethod":"t-test, 2 sided"},{"groupDescription":"Year 1","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.93","statisticalComment":"Significance level = 0.05","statisticalMethod":"t-test, 2 sided"},{"groupDescription":"Year 2","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.52","statisticalComment":"Significance level = 0.05","statisticalMethod":"t-test, 2 sided"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"6.3","value":"-1.5"},{"groupId":"OG001","spread":"6.4","value":"-2.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"title":"Week 30"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"5.1","value":"-2.3"},{"groupId":"OG001","spread":"7.3","value":"1.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"title":"Year 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"5.8","value":"-2.8"},{"groupId":"OG001","spread":"7.1","value":"-4.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"9"}],"units":"Participants"}],"title":"Year 2"}],"denoms":[{"counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"27"}],"units":"Participants"}],"description":"The Locke Marital Adjustment Test (LMAT) is a 16-item questionnaire with scores ranging from 48 to 138 for participants. Higher scores indicate greater sexual function, sexual wellbeing, or marital adjustment. The change in LMAT score is calculated by subtracting the baseline score from the follow-up score.","dispersionType":"Standard Error","groups":[{"description":"Beginning ≤ 7 days after the start of radiotherapy, patients receive oral tadalafil once daily for 24 weeks.","id":"OG000","title":"Tadalafil"},{"description":"Beginning ≤ 7 days after the start of radiotherapy, patients receive oral placebo once daily for 24 weeks.","id":"OG001","title":"Placebo"}],"paramType":"MEAN","populationDescription":"Consenting spouses of randomized, eligible patients with data at baseline and time point of interest","reportingStatus":"POSTED","timeFrame":"Baseline, week 30 and years 1 and 2 after the start of treatment","title":"Partner Marital Adjustment as Measured by the Locke's Marital Adjustment Test","type":"SECONDARY","unitOfMeasure":"change in LMAT score"}